These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 7992238

  • 1. Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist.
    Foster MR, Hornby EJ, Brown S, Hann M, Kitchin J, Pike N, Ward P.
    Thromb Res; 1994 Aug 01; 75(3):269-84. PubMed ID: 7992238
    [Abstract] [Full Text] [Related]

  • 2. Improved potency and specificity of Arg-Gly-Asp (RGD) containing peptides as fibrinogen receptor blocking drugs.
    Foster MR, Hornby EJ, Brown S, Kitchin J, Hann M, Ward P.
    Thromb Res; 1993 Nov 01; 72(3):231-45. PubMed ID: 8303662
    [Abstract] [Full Text] [Related]

  • 3. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine-aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function.
    Savage B, Marzec UM, Chao BH, Harker LA, Maraganore JM, Ruggeri ZM.
    J Biol Chem; 1990 Jul 15; 265(20):11766-72. PubMed ID: 2365698
    [Abstract] [Full Text] [Related]

  • 4. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
    Huang TF, Liu CZ, Ouyang CH, Teng CM.
    Biochem Pharmacol; 1991 Aug 22; 42(6):1209-19. PubMed ID: 1888330
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD, Seewaldt-Becker E, Himmelsbach F, Weisenberger H, Müller TH.
    J Cardiovasc Pharmacol; 1997 Aug 22; 30(2):261-72. PubMed ID: 9269956
    [Abstract] [Full Text] [Related]

  • 6. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata.
    Karczewski J, Endris R, Connolly TM.
    J Biol Chem; 1994 Mar 04; 269(9):6702-8. PubMed ID: 8120028
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic GPIIB/IIIA antagonist.
    Aoki T, Cox D, Senzaki K, Seki J, Tanaka A, Takasugi H, Motoyama Y.
    Thromb Res; 1996 Feb 15; 81(4):439-50. PubMed ID: 8907293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An echistatin-like Arg-Gly-Asp (RGD)-containing sequence in the heavy chain CDR3 of a murine monoclonal antibody that inhibits human platelet glycoprotein IIb/IIIa function.
    Deckmyn H, Stanssens P, Hoet B, Declerck PJ, Lauwereys M, Gansemans Y, Tornai I, Vermylen J.
    Br J Haematol; 1994 Jul 15; 87(3):562-71. PubMed ID: 7993797
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
    Ruggeri ZM, Houghten RA, Russell SR, Zimmerman TS.
    Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5708-12. PubMed ID: 3016716
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
    Huang TF, Holt JC, Lukasiewicz H, Niewiarowski S.
    J Biol Chem; 1987 Nov 25; 262(33):16157-63. PubMed ID: 3680247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S, Lu X, Kakkar VV, Authi KS.
    Biochem J; 1995 Nov 15; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.